chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Right breast tenderness/mild pain,  starting approximately 18 hrs after vaccine,  lasting approximately 48 hrs.  Fatigue beginning approximately 3 hrs post vaccine, lasting approximately 48-72 hrs.
This spontaneous report was received from a healthcare worker refers to an unspecified number of patients of unknown ages and genders. Since 20-MAY-2015 on unspecified dates, the patients were vaccinated with improperly stored (Oka/Merck) VARIVAX lot # L00456, Expiration date 06-JAN-2017 (dose and route not provided). No adverse effect reported. This is one of two reports received from the same source. Additional information has been requested.
I got up on the 09/03/22, my nose was running like crazy, I had a headache also. I thought it was my allergies so I just went out and did some yardwork. I was sneezing a lot and had some aches and pains. I took the home COVID-19 test thinking it would come back negative but it came it came back positive very fast. I called my doctor and to let them know. I was told to take Mucinex along with Lagevrio. I followed up with my PCP after still feeling bad for three weeks. I was put on antibiotics after a chest x-ray and I also have physical therapy to help my recovery after being sick for almost over a month.
feeling weak; hurt his head; headache / hurt his head; exhausted; nausea; muscle aches; joint aches; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (feeling weak), HEAD INJURY (hurt his head), HEADACHE (headache / hurt his head), FATIGUE (exhausted) and NAUSEA (nausea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 21-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (feeling weak), HEAD INJURY (hurt his head), HEADACHE (headache / hurt his head), FATIGUE (exhausted), NAUSEA (nausea), MYALGIA (muscle aches) and ARTHRALGIA (joint aches). At the time of the report, ASTHENIA (feeling weak), HEAD INJURY (hurt his head), HEADACHE (headache / hurt his head), FATIGUE (exhausted), NAUSEA (nausea), MYALGIA (muscle aches) and ARTHRALGIA (joint aches) outcome was unknown.            No concomitant medications provided. No treatment medications provided.
Severe heart inflammation; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDITIS (Severe heart inflammation) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYOCARDITIS (Severe heart inflammation) (seriousness criterion medically significant). At the time of the report, MYOCARDITIS (Severe heart inflammation) outcome was unknown.            No relevant concomitant medications were reported.   Very limited information regarding this event has been provided at this time, however, based on the available information, a causal relationship cannot be excluded.  Further information is not expected   Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Upon internal review on 04-AUG-2021, this case was revised and initials, age, gender, events related to patient were updated. Reporter type was updated. Vaccine information updated.; Sender's Comments: Very limited information regarding this event has been provided at this time, however, based on the available information, a causal relationship cannot be excluded.  Further information is not expected
Fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever). At the time of the report, PYREXIA (Fever) had not resolved.            No concomitant medications were reported. Treatment information was not provided.
c/o feeling jumpy, funny, fuzzy appeared apprehensive; BP 188/100, P92 strong & reg; hx of heart disease; inject site red & swollen;
No adverse effects reported; improperly stored doses of VARIVAX and PROQUAD; This spontaneous report was received from an administrator referring to patient of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On 28-MAR-2019 or 31-MAR-2019 or 02-APR-2019 or 03-APR-2019, the patient was vaccinated with an improperly stored dose of varicella virus vaccine live (oka/merck)(VARIVAX) with lot# R023736 with expiration date on 20-AUG-2020 or measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot numbers R008697 and R000551, for prophylaxis (dose and routes of administration). The administered doses of the vaccines experienced temperature excursion -12.85 degrees Celsius for 15 minutes. There was no adverse effect reported.  This call was because of a data logger and there was not previous temperature excursion.   No product quality complaint was involved.   Lot number R008697 and R000551 are invalid lot numbers for  measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) .  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-1904USA004741:Original Case : 1904USA003556 US-009507513-1904USA004742:Original Case : 1904USA003556 US-009507513-1904USA004743:Original Case : 1904USA003556 US-009507513-1904USA003556:Original Case : 1904USA003556 US-009507513-1904USA004739:Original Case : 1904USA003556 US-009507513-1904USA004740:Original Case : 1904USA003556
CONFIRMED COVID-19 INFECTION; STREPTOCOCCUS BACTERIAL INFECTION; This spontaneous report received from a patient concerned a 47 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included non-smoker, and alcoholic, and other pre-existing medical conditions included the patient had no known allergies. the patient did not have had any drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 203A21A, and expiry: 07-AUG-2021) dose was not reported, administered on 25-JUN-2021 13:00 for prophylactic vaccination. No concomitant medications were reported.  On 03-JUL-2021, the subject experienced streptococcus bacterial infection. Laboratory data included: Streptococcus identification test (NR: not provided) Positive. On 05-JUL-2021, the subject experienced confirmed covid-19 infection. Laboratory data included: Culture nose (NR: not provided) Positive. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from confirmed covid-19 infection, and the outcome of streptococcus bacterial infection was not reported. This report was non-serious.; Sender's Comments: V0 Medical assessment comment not required as per standard procedure as the case was assessed as non-serious.
COVID 19; This spontaneous case was reported by a health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (COVID 19) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concomitant products included METFORMIN, LISINOPRIL, METOPROLOL and LEVOTHYROXINE SODIUM (TIROSINT) for an unknown indication.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Jan-2021, the patient experienced COVID-19 (COVID 19). At the time of the report, COVID-19 (COVID 19) had not resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment medication details was reported.
Six patient(s) received  dose of Moderna vaccine beyond 30-day use by date; Received  dose of Moderna vaccine beyond 30-day use by date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Six patient(s) received dose of Moderna vaccine beyond 30-day use by date) and PRODUCT STORAGE ERROR (Six patient(s) received dose of Moderna vaccine beyond 30-day use by date) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003J21-2A) for COVID-19 vaccination.   No Medical History information was reported.   On 02-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2022, the patient experienced PRODUCT STORAGE ERROR (Six patient(s) received dose of Moderna vaccine beyond 30-day use by date). On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Six patient(s) received dose of Moderna vaccine beyond 30-day use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Six patient(s) received dose of Moderna vaccine beyond 30-day use by date) and PRODUCT STORAGE ERROR (Six patient(s) received dose of Moderna vaccine beyond 30-day use by date) outcome was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information was provided. HCP reports vial was brought to clinic and placed in refrigerator on 05-Jan-2022. No treatment medication information was provided.  Most recent FOLLOW-UP information incorporated above includes: On 04-Mar-2022: No new follow-up information received.
White blister rash that started at injection site then spread quickly over back, chest, other arm, legs.  Light headedness, and tingling and numbness in lips and face.  Was given Benadryl 25mg and  2 Tylenol.  The rash and numb feeling persisted for 3-4 hours.     Several hours later symptoms  were followed with a fever and nausea. These symptoms remedied within 24 hours and she was just tired and sore.
maculopapular rash, congestion, petechiae on face, cough, nausea/vomit x3 days starting 30AUG97;symptomatic treatment given;
Shingles outbreak.  Rash across left side of torso and chest and back.  Nerve pain ongoing for a couple weeks now Never had shingles before. Outbreak due to physical/mental stress factors is very unlikely.
HPI: ESRD, DM 2, hypertension; presented to ER for hypotension ; hx of dementia; given IV fluids in ER and started on antibiotics for pneumonia and a few L O2 via nasal cannula; dx'd with covid approx 10 days prior; treated with merrem and transitioned back to room air; family discussed making pt DNR and hospice care; pt had stable anemia and renal function; CXR showed improved perihilar infiltrate and persistent LLL pneumonia; pt was on 3L O2 via nc; meds: aouxaban 2.5 mg 1/2 tab bid; atorvastatin 20mg qd; D50W inj 12.5 gm = 25 ml iv push, as indicated prn, desvenlafaxine 50mg = 1 qd; dexamethasone 6mg = 0.6ml iv qd; flonase 50 mcg 100mcg 2 sprays nasal daily; glucagon 1mg prn, humalog qid, renvela 800mg 3 tab tid, singulair 10mg 1 tab qpm, sodium 650 mg 2 tabs bid, tylenol 650 2 tab q4h prn, zithromax, zofran 4mg 2ml iv push q8h prn, zosyn assessment: acute encephalopathy, hypotension resolved, ESRD on dialysis, dementia, acute respiratory failure with hypoxia, pneumonia due to COVID, not a candidate for remdesivir due to renal function, given decadron
Pain in arm; This case was reported by a other health professional via sales rep and described the occurrence of pain in arm in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix .5 ml. On an unknown date, unknown after receiving Shingrix, the patient experienced pain in arm. On an unknown date, the outcome of the pain in arm was recovered/resolved.   It was unknown if the reporter considered the pain in arm to be related to Shingrix.  Additional case details were reported as follows: The patient received Shingrix in left arm and said hurt on injection like the dickens and lasted 5-6 days.  The patient said all pain in arm resolved. For the tolerances of 2nd dose, refer case US2020AMR003917, reported by same reporter for the same patient.
SORE ALL OVER THE BODY; WEAKNESS IN BODY; HEADACHES; POSSIBLE BLOOD CLOT IN RIGHT LEG; SWELLING IN BOTH FEET; This spontaneous report received from a patient concerned a 57 year old. The patient's height, and weight were not reported. The patient's past medical history included accident affected right leg in 2010 and concurrent conditions included penicillin allergy (happened when patient was when very young) and severe back pain (from accident).  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043AZ1A, expiry: UNKNOWN) dose was not reported, 1 total, administered on 16-JUN-2021 on right arm for prophylactic vaccination. No concomitant medications were reported.  In JUN-2021 (week and a half after getting the vaccine), the patient had swelling in both feet but mostly in the right foot. The right foot swelled up during the day and then shrunk back down in the night. The skin looked pink and red and felt hot (warmth). The patient started noticing it when he started to experience pain in shins and then it got sore and then started to swell. The patient started noticing puffiness, soreness and warmth after. By 2 weeks it was very puffy and sore. The patient was able to walk and it was the right foot that was mainly bothering. The patient had not seen any health care professional during this time. The patient was concerned that he might had blood clot in right leg due to the fact that it was swollen, red and warm, as per the symptoms they read about. The patient had some headaches in the beginning, took aspirin, and it had improved. The patient also felt weak (weakness in body) and sore all over the body. These all had resolved except the right leg issue.  The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore all over the body, weakness in body, and headaches, and had not recovered from swelling in both feet, and possible blood clot in right leg. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: 20210713160-covid-19 vaccine ad26.cov2.- Possible blood clot in right leg. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Concurrent condition and medical history were not reported. On 15-JUL-2015 the patient was vaccinated with an improperly stored dose of (Oka/Merck) VARIVAX (lot # K021487, expiration date 03-NOV-2016) (Strength, dose and route were not reported). No adverse reactions were reported. This is one of several reports from the same source. Additional information has been requested.
shoulder cramp; mild fever; Shoulder cramped and was sore; chills; aches in your joints; like how you feel when you get the flu; dizzy; achiness; This spontaneous case was reported by a consumer and describes the occurrence of MUSCLE SPASMS (shoulder cramp), INFLUENZA LIKE ILLNESS (like how you feel when you get the flu), DIZZINESS (dizzy), PAIN (achiness) and PYREXIA (mild fever) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included HIV infection.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced MUSCLE SPASMS (shoulder cramp), PYREXIA (mild fever) and MYALGIA (Shoulder cramped and was sore). In May 2021, the patient experienced INFLUENZA LIKE ILLNESS (like how you feel when you get the flu), DIZZINESS (dizzy), PAIN (achiness), CHILLS (chills) and ARTHRALGIA (aches in your joints). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Adverse event, at an unspecified dose and frequency. On 04-May-2021, PYREXIA (mild fever) had resolved. In May 2021, MUSCLE SPASMS (shoulder cramp), INFLUENZA LIKE ILLNESS (like how you feel when you get the flu), DIZZINESS (dizzy), PAIN (achiness), MYALGIA (Shoulder cramped and was sore), CHILLS (chills) and ARTHRALGIA (aches in your joints) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were included HIV antiviral medications. He was not taking his antiviral medications for HIV at the time of the 1st dose of the vaccine After 2-3 days of vaccination started to experience dizziness. Dizziness occurred every night between 8-9pm. The aches were the worst between days 5-11 after vaccination.   This case was linked to MOD-2021-368949, MOD-2021-368955 (Patient Link).
Swollen Arm, Extremely tender, redness to follow stretching down to my forearm.  Started in axillary on 08th of March, moved to forearm by the 18th.
9/17/21: 13 minutes after I got headache with blurry vision, palpatations and nausea felt weird. at 5:20pm my face, neck tinglied felt swollen, feeling very dizzy and week at this point. 5:23PM took a baby aspirin (scared I might be stroking out).  9/18/21: very weak and tired rest all day baby aspirin morning and bedtime as I am still getting facial tingling and throat tightness, heart rate felt fast. 9/19/21: same as saturday, 9/20/21: facial tingling in morning took baby aspirin went to work at 1:28PM very very dizzing short of breath, nauseated headache and blurry vision co-worker took me to doctor. Negative labs doctor stated "most likely inflammatory reation to J&J vaccine. No arrhythmia"
11/08 - NOC noticed rash on (R) thigh @ vaccine admin site. Presented in clinic on 11/09 @ 0953am with 2", round erythematous, non tender, firm to touch, no drainage @ injection site.
Arthralgia, Numbness of upper gums and left nare lasting 30 minutes Narrative:
Information has been received from a registered nurse referring to a patient of unknown age and gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On 22-AUG-2014, the patient was vaccinated with the first dose of GARDASIL (lot # K001631 with expiration date 06-NOV-2016, dose and route were not reported). On 03-AUG-2015, the patient was vaccinated with the second dose of GARDASIL (lot # K010215 with expiration date 05-MAY-2017, dose and route were not reported) (inappropriate schedule of vaccine administered). On 09-OCT-2015, the patient was vaccinated with GARDASIL 9 reported as the "third dose"; lot # K026247 with expiration date 20-JAN-2017, dose unknown, intramuscular) (interchange of vaccine products). The outcome of the events was unknown. No product quality complaint (PQC) was involved. Additional information has been requested.
Pt was administered both FLUZONE HD and PNEUMOVAX 23 on 8/30/16. He was admitted to hospital for Guillain-Barre Syndrome. Sx: profound weakness in both legs, sweating, unsteady gait, fever 101 degree F, vomiting 2 times this week, abdominal pain. Pt can swallow; speech is normal.
Redness and blister left deltoid, redness (3-5mm) ferrous blister. Rx'd with Keflex for cellulitis.
pt recvd vax 8JAN93 & 16JAN93 devel a fever of 102; 18JAN93 had a sz; pt was taken to ER & observed for 6 hrs; pt was then seen by MD & treated w/unspecfied ATB & later recovered;
pt recvd vax; devel cellulitis characterized by redness, warmth & swelling; tx w/ keflex & dph;
I woke up in the middle of the night and I noticed that my heart was beating irregular. I decided to check my pulse and it was beating funny. I ignored it at first and it happened again a couple nights later. Sometimes I notice a third beat. Sometimes missing a beat. I went to my PCP first, but I was unable to get in to see the Cardiologist for a couple weeks. I ended up going to the emergency room and they diagnosed Premature Ventricular Contractions. I am also having hot flashes, so I am not drinking as much coffee or soda.
Numbness and tingling in hands and feet followed by severe pain. Symptoms then spreaded up both legs and arms and then to face. Trouble speaking and swallowing. Was admitted to hospital went to ICU for over 15 days. Diagnosed with ICU psychosis. Pneumonia.
Right upper arm erythematous and edematous.  Pt was seen in ER of clinic, diagnosed with cellulitis and placed on Keflex 250mg three times a day.  No fever.
Significant fever 8 hours after administration. Hallucinating at night and high temperature. Fever broke after waking up the next morning.
A non-serious spontaneous report of received expired FLUMIST was received from a health professional concerning an adult patient. Neither the patient's past medical history nor the concomitant medications were reported. The product expired in Feb-2010. The patient received the expired FLUMIST on 17-Jan-2011. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
Information has been received from a registered nurse referring to a patient of unknown age and gender. On an unknown date one dose of improperly stored GARDASIL, lot # unspecified, 0.5 ml/1 dose, intramuscularly was administered to the patient. No adverse effects were reported. Additional information has been requested.
Had a floater in Left eye for 4/5 days, started  last week for a few.    Diarrhea several times since the shot (no big deal although more than normal).  This last one is the one I'm concerned about believe I have a UTI infection for the last 5 days, self treating with many products.  It's getting a little better ... just concerned.    Wondering if I should get an antibody test before the second shot ..... HELP!
post menopausal and haven't had a period in 3 1/2 years. 2 weeks after vaccination in having vaginally bleeding; This is a spontaneous report from a contactable consumer (the patient). A 49-year-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 08Apr2021 13:45 (at the age of 49-years-old) as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation at hospital. Medical history included ongoing post menopausal (I am post menopausal and haven't had a period in 3 1/2 years). There were no concomitant medications. The patient had no allergies. The patient did not receive any other vaccine in four weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID. The patient was post menopausal and haven't had a period in 3 1/2 years. 2 weeks after vaccination in having vaginally bleeding on 23Apr2021 17:30. The patient did not receive any treatment for the event. The outcome of event was not recovered.  No follow-up attempts are possible. No further information is expected.
Headache, Myalgia, Arthralgia, Fever, Chills, fatigue Narrative:  Other Relevant History:
pt recvd vax 15OCT93 & reported seen @ clinic 25OCT w/maculopapula lesions on face, arms, trunk; t98.5 but had low fever on Friday; No known exposure to measles;